XTL BIOPHARMACEUTICALS LTD | CIK:0001023549 | 3

  • Filed: 3/15/2018
  • Entity registrant name: XTL BIOPHARMACEUTICALS LTD (CIK: 0001023549)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/0001213900-18-003028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/xtlb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001023549
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfRelatedPartyExplanatory

    NOTE 21:TRANSACTIONS AND BALANCES WITH RELATED PARTIES

     

    “Related party” - as the term is defined in IAS 24, “Related Party Disclosures” (“IAS 24”).

     

    The Company’s key management personnel who are included, along with other factors, in the definition of related party, as above in IAS 24, includes directors and members of the executive committee.

     

    Compensation to key management personnel:

     

    The compensation to key management personnel for employee services provided to the Company is shown below:

     

      Year ended December 31, 
      2017  2016  2015 
      U.S. dollars in thousands 
              
    Salaries, management and consulting fees and other short-term benefits  373   407   487 
    Pension, post retirement and other benefits  12   17   16 
    Share-based payments, net  39   127   143 
                 
       424   551   646 
                 
    Number of persons  9   10   11 

     

    As of December 31, 2017 and 2016, the Company’s balances with related parties total approximately $24 thousand ($24 thousand out of which were linked to the NIS) and $61 thousand (of which $46 thousand were linked to the NIS), respectively.

     

    For further information regarding share-based payment to related parties, see also Note 16 above.